October 19, 2020

The Niche

Knoepfler lab stem cell blog

stem cell patient safety

3 min read

IntelliCell BioSciences, Inc. of New York, a clinical stem cell establishment, has had a rough time of it lately. For example, a recent piece of bad news is that there is an impending foreclosure sale of the company’s assets. What exactly that means for the company more broadly remains unknown, but a few people tell me (take this with a grain of salt either way) that the company is still seeing patients. IntelliCell also has run into issues on multiple occasions including in 2012 with the FDA …Read More